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Epidermolysis bullosa with pyloric atresia (EB-PA), manifesting with neonatal blistering and gastric anomalies, is
known to be caused by mutations in the hemidesmosomal genes ITGA6 and ITGB4, which encode the a6 and b4
integrin polypeptides, respectively. As part of our molecular diagnostics program, we have now encountered four
families with EB-PA in which no mutations could be identiﬁed in these two genes. Instead, PCR ampliﬁcation
followed by heteroduplex scanning and/or direct nucleotide sequencing revealed homozygous mutations in the
plectin gene (PLEC1), encoding another hemidesmosomal protein previously linked to EB with muscular dystro-
phy. Our ﬁndings provide evidence for additional molecular heterogeneity in EB, and emphasize the importance of
screening EB-PA patients not only for a6b4 integrin but also for plectin deﬁciency.
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Epidermolysis bullosa (EB) is a phenotypically diverse group
of heritable mechanobullous disorders characterized by
blistering and erosions of the skin and mucous membranes
(Fine et al, 2000). Ten different genes expressed within the
cutaneous basement membrane zone are now known to
harbor mutations that underlie different forms of EB
(Pulkkinen and Uitto, 1999; Uitto and Richard, 2004). Add-
ing to the phenotypic complexity of EB is the fact that
several well-characterized variants are associated with
extracutaneous manifestations with considerable morbidity
and mortality (Uitto et al, 1997; Fine et al, 2000). One of
these variants, EB with pyloric atresia (EB-PA; OMIM
#226730), manifests with neonatal blistering associated
with PA, a combination that can lead to early postnatal de-
mise of the affected individuals. EB-PA has been shown to
result in most families from mutations in the genes encoding
the subunit polypeptides of a6b4 integrin, ITGA6 and IT-
GB4, respectively (Pulkkinen and Uitto, 1998; Pulkkinen
et al, 1998). Another variant, EB with muscular dystrophy
(EB-MD; OMIM #226670), is characterized by neonatal blis-
tering accompanied by proximal muscle weakness that can
develop during childhood (early onset) or in the third or
fourth decade of life (late onset). EB-MD is caused by mu-
tations in the gene encoding plectin, PLEC1 (GeneBank
U53204), which is expressed not only in the hemidesmo-
somes but also in the sarcolemma and the Z-lines of the
skeletal muscle (Uitto et al, 1996).
As part of the diagnostic services to the global EB patient
community provided by the DebRA Molecular Diagnostics
Laboratory, which was established at Jefferson Medical
College in 1996, we have analyzed approximately 1000
families with different forms of EB, including 35 families with
EB-PA. A total of 56 distinct mutations in the EB-PA families
have been identified in the ITGB4 gene (see Pulkkinen et al,
1998; Nakano et al, 2001) and four of them in the ITGA6
gene (Pulkkinen et al, 1997; Ruzzi et al, 1997). In this report,
we describe four cases with EB and PA and neonatal le-
thality in which analysis of the ITGB4 and ITGA6 genes,
including direct sequencing of exons and flanking intronic
sequences, yielded no pathogenetic mutations. Subse-
quent mutation analysis of PLEC1, however, identified ho-
mozygous mutations in each case.
The proband in each family was a newborn with clinical
findings of blistering and PA, and they died from complica-
tions of the disease shortly after birth. Information on the
families as well as clinical and diagnostic features of the
proband are included in Fig 1 and Table I. These studies
were approved by the Institutional Review Board of Thomas
Jefferson University, and they adhere to Declaration of Hel-
sinki principles. A written informed consent was obtained
from the patients or their guardians. PCR amplification of 33
exons of PLEC1, followed by heteroduplex scanning and/or
direct dideoxynucleotide sequencing of the probands’ and/
or parents’ DNA resulted in identification of homozygous
mutations in each family (Fig 2). The parents were found to
be heterozygous carriers of the corresponding mutations,
consistent with consanguinity in each family (see Fig 1). Two
of the mutations, Q305X and Q3029X (cases 2 and 3, re-
spectively), were nonsense mutations resulting from C-to-T
transitions and reflecting hypermutability of putative 5-me-
thylcytosine within exons 10 and 33, respectively. One
of the mutations (case 1) was an out-of-frame deletion,
1563del4, predicting a premature stop-codon 30 bp down-
stream from the site of deletion within exon 15. Finally,
Abbreviations: EB, epidermolysis bullosa; EB-MD, EB with mus-
cular dystrophy; EB-PA, EB with pyloric atresia
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Figure 1
Nuclear pedigrees of the families with epidermolysis bullosa with pyloric atresia (EB-PA). Solid symbols denote children who died from
complications of the disease shortly after birth. Note consanguinity in each family.
Table I. Plectin gene mutations in families with epidermolysis bullosa with pyloric atresia (EB-PA)
Family
no. Ethnic origin
Consanguinity
(parents)
Clinical features of the
proband
Diagnostic skina
pathology
Mutationsb
maternal/paternal
1 Pakistani Distant cousins Blistering and PA at birth;
two similarly affected older
siblings
EM: low basal cell cytolysis;
attenuation of anchoring
filaments; rudimentary
hemidesmosomes
1563del4/1563del4
(1614del4/1614del4)
2 Lebanese First cousins Extensive blistering; aplasia
cutis of abdomen and legs;
ear abnormalities
IF: laminin 5, uncein, and
type VII collagen expressed
at the base of an intra-
epidermal cleft
Q305X/Q305X
3 Saudi Arabian First cousins Blistering and PA at birth;
another sibling with neonatal
demise
IF: a6b4 staining normal R3029X/R3029X
4 Caucasian Second cousins Extensive blistering and
aplasia cutis at birth; poly-
hydramnion
EM: lamina lucida cleavage;
hypoplastic
hemidesmosomes; IF:
collagen XVII/BPAG2
staining negative; collagen
VII staining normal
2769del21/2769del21
(2820del21/2829del21)
aEM, electron microscopy; IF, immunofluorescence; Please note that immunofluorescence for plectin was not done in any of the cases.
bThe mutations in the plectin gene (PLEC1; GeneBank U53204) refer to nucleotide positions of the gene counting the translation initiation codon ATG
as 1–3, as published by McLean et al (1996); the numbers in parentheses refer to positions of the corresponding nucleotides counting the beginning of
the published gene sequence (51) as 1.
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Figure 2
Nucleotide sequencing data documenting mutations in the PLEC1 gene in Families 1–4 with epidermolysis bullosa (EB) with pyloric atresia.
Family 1: The proband is homozygous and the parents are heterozygous for a 4-bp deletion mutation, 1563del4. Family 2: The proband is
homozygous and the parents are heterozygous for the nonsense mutation Q305X. Family 3: The proband is homozygous and the parents (mother
only shown) are heterozygous for the nonsense mutation R3029X. Family 4: The parents (mother only shown) are heterozygous for a 21-bp deletion
mutation. No DNA was available from the proband, whereas a normal control sequence is shown for reference.
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another mutation (case 4) was a 21-bp in-frame deletion,
2769del21, within exon 23, resulting in loss of seven amino
acids.
Plectin, a large (  500 kDa) multidomain adhesion mol-
ecule, is expressed in a broad spectrum of tissues and cells,
including epithelial cells, muscle, and neural tissues (Wiche,
1998). In the skin, plectin is concentrated at the basal layer
of epidermal cells where it is a component of both hem-
idesmosomes and desmosomes (Koster et al, 2004). In
hemidesmosomes, this protein directly links the intermedi-
ate filaments to the cytoplasmic domain of the b4 integrin
subunit and to the 180 kDa bullous pemphigoid antigen, a
transmembrane collagen, type XVII (Schaapveld et al, 1998;
Koster et al, 2003). The corresponding gene, PLEC1, is lo-
cated on chromosomal locus 8q24 in the human genome
and encodes 33 exons (Liu et al, 1996; McLean et al, 1996).
Analysis of the murine plectin gene has revealed that there
are as many as 16 plectin variants because of alternatively
spliced exons in the 50 region of the gene, and the tissue
expression of the various plectin variants is different, sug-
gesting distinct functions for the different isoforms (Elliott
et al, 1997; Fuchs et al, 1999).
Plectin mutations have previously been identified in EB-
MD, an autosomal recessive disorder with neonatal blister-
ing and delayed, progressive MD (McLean et al, 1996;
Pulkkinen et al, 1996; Smith et al, 1996; Rouan et al, 2000).
These mutations are, in general, nonsense mutations or out-
of-frame insertions or deletions within exon 32, and they
result in premature stop-codons predicting truncated poly-
peptides and downregulation of the corresponding mRNA
through nonsense-mediated mRNA decay (Shimizu et al,
1999). In these patients, immunofluorescence with a mono-
clonal antibody (Mab 121), which is directed against an
epitope within the plectin rod domain (Okumura et al, 1999),
is often completely negative. Several cell types, including
keratinocytes, express a naturally occurring splice variant of
plectin that lacks the rod domain (Elliott et al, 1997), and it is
conceivable, therefore, that low levels of the truncated po-
lypeptides are expressed from the mutant alleles. Never-
theless, the pathogenetic role of plectin mutations in these
patients is attested to by mice in which the plectin gene has
been inactivated by targeted ablation. These mice, in
addition to blistering within the basal keratinocytes, show
necrotic muscle fibers with disorganized myofibrils and
sarcomeres (Andra et al, 1997). In addition to autosomal
recessive EB-MD, an autosomal dominant form of EB sim-
plex, the Ogna variant, has been shown to result from a
heterozygous missense mutation (R2110W) (Koss-Harnes
et al, 2003). These patients do not develop muscle symp-
toms, and there is no evidence of PA.
This report provides a description of plectin mutations in
multiple families with EB-PA, and similar observations have
been made on two Japanese patients with EB-PA and neo-
natal lethality (Nakamura et al, 2004). Furthermore, a recent
study (Charlesworth et al, 2003) reported a novel ho-
mozygous plectin mutation (2727del14) associated with a
lethal form of recessive EB in a consanguinous family with
three affected offspring. This new variant of EB was char-
acterized by generalized blistering, aplasia cutis of the
limbs, complex developmental anomalies, and rapid demise
after birth, clinical features shared by the patients in our
series. One of the three siblings was suspected by ultra-
sound at the 25th wk of gestation to have ‘‘obstruction of
the gastric outlet’’, but the occurrence of PA was subse-
quently not substantiated (Charlesworth et al, 2003).
The majority of patients with EB-PA have mutations in the
a6b4 integrin genes. It should be noted, however, that a
homozygous missense mutation (G931D) in the cytoplasmic
tail of b4 integrin has been reported in a form of non-Herlitz
junctional EB without PA (Inoue et al, 2000). Nevertheless,
the gastrointestinal phenotype, i.e., PA, reported in these
patients may be related to perturbed interactions between
plectin and a6b4 integrin within attachment structures ex-
pressed during gastrointestinal development (Rezniczek
et al, 1998; Nievers et al, 2000; Koster et al, 2001). In par-
ticular, the in-frame deletion 2769del21 in case 4 results in
elimination of seven amino acids that may be critical for
such interactions. It is also of interest that two of the stop-
codon causing mutations reported in this study reside with-
in exons 15 (case 1) and 10 (case 2), upstream from the
previously reported stop-codon mutations within the rod
domain. In these cases, differences in the size of the trun-
cated polypeptides, if expressed at low levels, may explain
the phenotypic variability (EB-PA vs EB-MD) resulting from
mutations in the PLEC1 gene. Finally, the stop-codon
mutation in exon 33 (case 3) could have led to muscle in-
volvement, similar to other premature-termination codon
mutations in exon 32; however, this hypothesis could
not be verified because of early demise of the affected
individual.
Collectively, our findings attest to additional molecular
heterogeneity in EB, and they emphasize the importance of
screening of EB-PA patients by immunofluorescence not
only for a6b4 integrin but also for plectin deficiency. Iden-
tification of mutations in the plectin gene provides the op-
portunity for prenatal diagnosis in these families at risk for
recurrence of EB-PA (Pfendner et al, 2003).
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